These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9108779)
1. N-alpha-tosyl-L-lysine chloromethylketone prevents expression of iNOS in vascular smooth muscle by blocking activation of NF-kappa B. Schini-Kerth VB; Boese M; Busse R; Fisslthaler B; Mülsch A Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):672-9. PubMed ID: 9108779 [TBL] [Abstract][Full Text] [Related]
2. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP. Boese M; Busse R; Mülsch A; Schini-Kerth V Br J Pharmacol; 1996 Oct; 119(4):707-15. PubMed ID: 8904645 [TBL] [Abstract][Full Text] [Related]
3. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle. Kessler P; Kronemann N; Hecker M; Busse R; Schini-Kerth VB J Cardiovasc Pharmacol; 1997 Dec; 30(6):802-10. PubMed ID: 9436821 [TBL] [Abstract][Full Text] [Related]
4. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta. Hecker M; Preiss C; Schini-Kerth VB Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219 [TBL] [Abstract][Full Text] [Related]
5. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691 [TBL] [Abstract][Full Text] [Related]
6. Role of nuclear factor kappa B in cytokine-induced nitric oxide and tetrahydrobiopterin synthesis in rat neonatal cardiac myocytes. Hattori Y; Nakanishi N; Kasai K J Mol Cell Cardiol; 1997 Jun; 29(6):1585-92. PubMed ID: 9220344 [TBL] [Abstract][Full Text] [Related]
7. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha. Katsuyama K; Hirata Y J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells. Zhou J; Struthers AD; Lyles GA Pharmacol Res; 1999 May; 39(5):363-73. PubMed ID: 10328994 [TBL] [Abstract][Full Text] [Related]
9. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Katsuyama K; Shichiri M; Marumo F; Hirata Y Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459 [TBL] [Abstract][Full Text] [Related]
10. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells. Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. Hattori Y; Hattori S; Kasai K Eur J Pharmacol; 2003 Nov; 481(2-3):153-8. PubMed ID: 14642780 [TBL] [Abstract][Full Text] [Related]
12. Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins. Durante W; Kroll MH; Orloff GJ; Cunningham JM; Scott-Burden T; Vanhoutte PM; Schafer AI Biochem Pharmacol; 1996 Mar; 51(6):847-53. PubMed ID: 8602881 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 beta induced activation of NF-kappa B in insulin producing RINm5F cells is prevented by the protease inhibitor N alpha-p-tosyl-L-lysine chloromethylketone. Saldeen J; Welsh N Biochem Biophys Res Commun; 1994 Aug; 203(1):149-55. PubMed ID: 8074648 [TBL] [Abstract][Full Text] [Related]
15. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells. Doi M; Shichiri M; Katsuyama K; Marumo F; Hirata Y Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279 [TBL] [Abstract][Full Text] [Related]
16. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970 [TBL] [Abstract][Full Text] [Related]
17. Amlodipine increases nitric oxide synthesis in cytokine-stimulated cultured vascualar smooth muscle cells. Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Ikeda M; Minota S; Shimada K J Hypertens; 2000 Nov; 18(11):1597-604. PubMed ID: 11081772 [TBL] [Abstract][Full Text] [Related]
18. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B. Kim H; Lee HS; Chang KT; Ko TH; Baek KJ; Kwon NS J Immunol; 1995 May; 154(9):4741-8. PubMed ID: 7536778 [TBL] [Abstract][Full Text] [Related]
19. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Katsuyama K; Shichiri M; Marumo F; Hirata Y Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920 [TBL] [Abstract][Full Text] [Related]
20. Gliadin increases iNOS gene expression in interferon-gamma-stimulated RAW 264.7 cells through a mechanism involving NF-kappa B. Maiuri MC; De Stefano D; Mele G; Iovine B; Bevilacqua MA; Greco L; Auricchio S; Carnuccio R Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):63-71. PubMed ID: 12845421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]